<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table II Cardiac Events and All-Cause Mortality (events per 1000 patients) Occurring During the 3.5 Year Open-Label Follow-up to the Helsinki Heart Study*</caption>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<th valign="top">Group:</th>
<th align="center">PDrop</th>
<th align="center">PN</th>
<th align="center">PG</th>
<th align="center">GDrop</th>
<th align="center">GN</th>
<th align="center">GG</th>
</tr>
<tr>
<th></th>
<th>N=215</th>
<th align="center">N=494</th>
<th align="center">N=1283</th>
<th align="center">N=221</th>
<th align="center">N=574</th>
<th align="center">N=1207</th>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="7">*The six open-label groups are designated first by the original randomization (P = placebo, G = Gemfibrozil Tablets) and then by the drug taken in the follow-up period (N = Attend clinic but took no drug, G = Gemfibrozil Tablets, Drop = No attendance at clinic during open-label). </td>
</tr>
</tfoot>
<tbody>
<tr>
<td> Cardiac Events</td>
<td align="center"> 38.8</td>
<td align="center"> 22.9</td>
<td align="center"> 22.5</td>
<td align="center"> 37.2</td>
<td align="center"> 28.3</td>
<td align="center"> 25.4</td>
</tr>
<tr>
<td> All-Cause Mortality</td>
<td align="center"> 41.9</td>
<td align="center"> 22.3</td>
<td align="center"> 15.6</td>
<td align="center"> 72.3</td>
<td align="center"> 19.2</td>
<td align="center"> 24.9</td>
</tr>
</tbody>
</table>